Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 11Unknown 5Terminated 3Withdrawn 1

Sponsor Class

NIH 5

Study Type

Observational 4Interventional 1

Sponsor

Cancer Type

Genitourinary 6Breast 6Other hematologic neoplasm 5Dermatologic 5Lymphoid 3Thoracic 2Sarcoma 2Gynecologic 2Gastrointestinal 2Tumor-Agnostic 1Other solid neoplasm 1Other neoplasm 1Myeloid 1Head & Neck 1

Conditions

Melanoma 5Melanoma, Cutaneous Malignant 1

Interventions

Nivolumab 25pembrolizumab 21Ipilimumab 15Temozolomide 13toripalimab 12Biopsy 10Imiquimod 8Cyclophosphamide 8Dacarbazine 7Blood Specimen Collection 7camrelizumab 6Chemotherapy, Adjuvant 6trametinib 5dabrafenib 5atezolizumab 5aldesleukin 5Gene Expression Profiling 5Cisplatin 5Aminolevulinic Acid 5fludarabine phosphate 4fludarabine 4durvalumab 4binimetinib 4apatinib 4Tomography, Optical Coherence 4Sorafenib 4Photochemotherapy 4Injections 4Bevacizumab 4tislelizumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Gene Expression Profiling × Dermatologic × Clear all
NCT00445783 2013-08-12

Study of Families With Melanoma

National Cancer Institute (NCI)

Unknown
3,700 enrolled
Dermatologic

Melanoma

NCT00450593 2013-08-12

Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma

National Cancer Institute (NCI)

Unknown
5,000 enrolled
Dermatologic

Melanoma, Cutaneous Malignant, Melanoma

NCT00672321 2013-08-12

Answering Questions About Vitamin D Supplementation and Sun Exposure in Patients Who Have Undergone Surgery for Stage IB, Stage II, or Stage IIIA Melanoma

National Cancer Institute (NCI)

Unknown
2,774 enrolled
Dermatologic

Melanoma

NCT00897481 2013-08-12

Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy

National Cancer Institute (NCI)

Unknown
1,000 enrolled
Dermatologic

Melanoma

NCT00811759 2010-10-07

Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma

National Cancer Institute (NCI)

Phase 1/2 Unknown
58 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡